Literature DB >> 16474160

Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.

Wu Ou1, Ning Lu, Sloane S Yu, Jonathan Silver.   

Abstract

The membrane-proximal region of the human immunodeficiency virus type 1 (HIV-1) transmembrane protein (TM) is critical for envelope (Env)-mediated membrane fusion and contains the target for broadly reactive neutralizing antibody 2F5. It has been proposed that 2F5 neutralization might involve interaction of its long, hydrophobic, complementarity-determining region (CDR) H3, with adjacent viral membrane. Using Moloney murine leukemia virus (MLV) as a tool, we examined the effect of epitope position on 2F5 neutralization. When the 2F5 epitope was inserted in the proline-rich region of MLV Env surface protein (SU), 2F5 blocked cell fusion and virus infection, whereas MLV with a hemagglutinin (HA) epitope at the same position was not neutralized by anti-HA, even though the antibodies bound their respective Envs on the surface of infected cells and viruses equally well. When the 2F5 epitope was inserted in the MLV Env TM at a position comparable to its natural position in HIV-1 TM, 2F5 antibody blocked Env-mediated cell fusion. Epitope position had subtle effects on neutralization by 2F5: the antibody concentration for 50% inhibition of cell fusion was more than 10-fold lower when the 2F5 epitope was in SU than in TM, and inhibition was less complete at high concentrations of antibody; we discuss possible explanations for these effects of epitope position. Since membrane proximity was not required for neutralization by 2F5 antibody, we speculate that the CDR H3 of 2F5 contributes to neutralization by destabilizing an adjacent protein rather than by inserting into an adjacent membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474160      PMCID: PMC1395390          DOI: 10.1128/JVI.80.5.2539-2547.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.

Authors:  E Coëffier; J M Clément; V Cussac; N Khodaei-Boorane; M Jehanno; M Rojas; A Dridi; M Latour; R El Habib; F Barré-Sinoussi; M Hofnung; C Leclerc
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

Review 2.  A model for neutralization of viruses based on antibody coating of the virion surface.

Authors:  D R Burton; E O Saphire; P W Parren
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 3.  Mechanisms of virus neutralization by antibody.

Authors:  P J Klasse; Q J Sattentau
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

4.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.

Authors:  P W Parren; I Mondor; D Naniche; H J Ditzel; P J Klasse; D R Burton; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity.

Authors:  V von Messling; G Zimmer; G Herrler; L Haas; R Cattaneo
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

8.  Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion.

Authors:  E Schmid; A Zurbriggen; U Gassen; B Rima; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells.

Authors:  R Kunert; W Steinfellner; M Purtscher; A Assadian; H Katinger
Journal:  Biotechnol Bioeng       Date:  2000-01-05       Impact factor: 4.530

10.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more
  9 in total

1.  Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization.

Authors:  Wu Ou; Jonathan Silver
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

Review 2.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

3.  Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.

Authors:  George Sellhorn; Zane Kraft; Zachary Caldwell; Katharine Ellingson; Christine Mineart; Michael S Seaman; David C Montefiori; Eliza Lagerquist; Leonidas Stamatatos
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

4.  Cooperative cleavage of the R peptide in the Env trimer of Moloney murine leukemia virus facilitates its maturation for fusion competence.

Authors:  Robin Löving; Malin Kronqvist; Mathilda Sjöberg; Henrik Garoff
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.

Authors:  Pengcheng Wang; Xinzhen Yang
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

6.  Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization.

Authors:  Emma T Crooks; Pengfei Jiang; Michael Franti; Sharon Wong; Michael B Zwick; James A Hoxie; James E Robinson; Penny L Moore; James M Binley
Journal:  Virology       Date:  2008-06-09       Impact factor: 3.616

7.  The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.

Authors:  Nerea Huarte; Maier Lorizate; Rubén Maeso; Renate Kunert; Rocio Arranz; José M Valpuesta; José L Nieva
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

8.  Novel postentry resistance to AKV ecotropic mouse gammaretroviruses in the African pygmy mouse, Mus minutoides.

Authors:  Yuhe Yan; Christine A Kozak
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage.

Authors:  Ryan C Knoper; John Ferrarone; Yuhe Yan; Bernard A P Lafont; Christine A Kozak
Journal:  Virology       Date:  2009-07-07       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.